May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema
Author Affiliations & Notes
  • J.J. Chieh
    Ophthalmology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, United States
  • M. Liu
    Retina Service, Wills Eye Hospital, Philadelphia, PA, United States
  • A. Martidis
    Retina Service, Wills Eye Hospital, Philadelphia, PA, United States
  • D.B. Roth
    Retina Service, Wills Eye Hospital, Philadelphia, PA, United States
  • J. Belmont
    Retina Service, Wills Eye Hospital, Philadelphia, PA, United States
  • M. Nelson
    Retina Service, Wills Eye Hospital, Philadelphia, PA, United States
  • C. Regillo
    Retina Service, Wills Eye Hospital, Philadelphia, PA, United States
  • A. Sivalingam
    Retina Service, Wills Eye Hospital, Philadelphia, PA, United States
  • J. Federman
    Retina Service, Wills Eye Hospital, Philadelphia, PA, United States
  • Footnotes
    Commercial Relationships  J.J. Chieh, None; M. Liu, None; A. Martidis, None; D.B. Roth, None; J. Belmont, None; M. Nelson, None; C. Regillo, None; A. Sivalingam, None; J. Federman, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3220. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.J. Chieh, M. Liu, A. Martidis, D.B. Roth, J. Belmont, M. Nelson, C. Regillo, A. Sivalingam, J. Federman; Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3220.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate the efficacy of intravitreal triaminolone acetonide (IVT) for the treatment of diabetic macular edema. Methods: Retrospective analysis of the records of 218 patients from 2 institutions with diabetic macular edema who were treated with IVT. Results: Two Hundred and thirty-two eyes of 218 patients with diabetic macular edema were treated with IVT . Mean follow-up was 6.1 months. One hundred and seventy eight eyes (76.7%) had nonproliferative diabetic retinopathy (NPDR) and 54 eyes (23.3%) had proliferative diabetic retinopathy (PDR). One hundred and ninety five eyes (84.1%) were treated with prior focal laser photocoagulation at least once. The mean visual acuity pre-operatively was 20/160. The mean visual acuities were 20/120, 20/120, and 20/140 at 1, 3, and 6 months, respectively. One hundred and forty-one eyes had clinical resolution of macular edema (61%). Forty eyes (17.3%) were treated more than once. Visual outcomes were limited by subsequent development of vitreous hemorrhage and macular ischemia in some patients. Conclusions: IVT was successful in reducing clinical macular edema in eyes with diabetic retinopathy, but visual acuity may not always improve in eyes with diabetic macular edema.

Keywords: clinical (human) or epidemiologic studies: out • eicosanoids • diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×